- Home
- ERAS vs TDOC Comparison
ERAS vs TDOC Comparison
Compare ERAS & TDOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ERAS | TDOC |
|---|---|---|
| Founded | 2018 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ERAS | TDOC |
|---|---|---|
| Price | $9.53 | $6.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 14 |
| Target Price | $5.33 | ★ $9.42 |
| AVG Volume (30 Days) | ★ 7.9M | 5.1M |
| Earning Date | 11-12-2025 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,528,199,000.00 |
| Revenue This Year | N/A | $0.13 |
| Revenue Next Year | N/A | $1.01 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.01 | $6.26 |
| 52 Week High | $9.87 | $15.21 |
Technical Indicators
Market Signals| Indicator | ERAS | TDOC |
|---|---|---|
| Relative Strength Index (RSI) | 88.98 | 28.96 |
| Support Level | $3.36 | $6.90 |
| Resistance Level | $6.49 | $8.06 |
| Average True Range (ATR) | 1.01 | 0.31 |
| MACD | 0.57 | -0.12 |
| Stochastic Oscillator | 92.85 | 0.25 |
Price Performance
Historical ComparisonAbout ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About TDOC Teladoc Health Inc.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.